Chemotherapy Foundation Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 1,809,722 | 2,868,627 | −1,058,905 | 29.1 | 6% |
| 2012 | 1,689,197 | 2,631,798 | −942,601 | 27.9 | 7% |
| 2013 | 1,654,541 | 2,336,403 | −681,862 | 26.6 | 8% |
| 2014 | 1,118,428 | 1,836,251 | −717,823 | 29.2 | 10% |
| 2015 | 651,003 | 1,162,759 | −511,756 | 38.3 | 16% |
| 2016 | 381,904 | 1,037,832 | −655,928 | 35.9 | 18% |
| 2017 | 467,956 | 1,035,319 | −567,363 | 29.4 | 12% |
| 2018 | 470,966 | 1,108,269 | −637,303 | 20.6 | 11% |
| 2019 | 330,202 | 1,019,751 | −689,549 | 15.1 | 17% |
| 2020 | 167,301 | 430,444 | −263,143 | 25.2 | 28% |
| 2021 | 563,954 | 627,801 | −63,847 | 16.1 | 19% |
| 2022 | 178,027 | 463,847 | −285,820 | 12.7 | 26% |
| 2023 | 79,579 | 374,746 | −295,167 | 9.0 | 32% |
In its most recent public year (2023), this organization spent $295,167 more than it brought in. Its reserves stood at about 9 months of spending, down from 29.1 in 2011. Staff pay was 32% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Chemotherapy Foundation Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works